BOBULSKY SUSAN (SVP, Diagnostics, clonoSEQ) sold 1.2% of their position (5K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $95.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/15/2026ACC: 0001820885-26-000010
Officer· SVP, Diagnostics, clonoSEQ
Since Aug 2020
-5K
Net shares
Net seller
$95.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5K
Price / share
$19.00
Trade value
$95K
% of position
1.2%
6/11/2026
416.77K→411.77K
Total
Net shares
−5K
Net value
-$95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2026 | S · Sale | −5K | $19.00 | $95K | 1.2% | 416.77K | 411.77K |
| Total | −5K | -$95K | ||||||
Derivative Transactions0
No derivative transactions reported